No Competing Here

Aled Edwards, the CEO of the Structural Genomics Consortium, tells the Globe and Mail that it makes no sense for pharmaceutical scientists at different organizations to be working on the same problems. "The semiconductor industry in the '80s started to collaborate with one another on the platform," Edwards says. "They said: Every one of us generating a unique platform on which to build our hardware is silly, right?

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.